Published in J Clin Microbiol on November 01, 1989
Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun (1995) 1.35
A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiol Infect (1993) 1.28
Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. Emerg Infect Dis (2011) 0.75
Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease. Appl Microbiol Biotechnol (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Antibiotic-associated pseudomembranous colitis. Rev Infect Dis (1980) 3.02
Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis (1983) 2.03
Serotyping of Clostridium difficile. J Clin Microbiol (1988) 1.98
Diarrhea and colitis associated with antimicrobial therapy in man and animals. Am J Clin Nutr (1979) 1.76
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains. J Med Microbiol (1985) 1.38
Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions. J Clin Microbiol (1988) 1.07
Evidence for cross-infection in an outbreak of Clostridium difficile-associated diarrhoea in a surgical unit. J Med Microbiol (1988) 0.99
Cytotoxin and enterotoxin production by Clostridium difficile. Microbiologica (1984) 0.94
Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea. J Immunol Methods (1983) 0.92
Antitoxin production in antibiotic-associated colitis? J Clin Pathol (1981) 0.82
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med (1996) 4.86
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect (2007) 3.27
A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect (2003) 1.94
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem (1998) 1.83
Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer. Gynecol Oncol (1994) 1.42
Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool samples from adults and children in Italy. Clin Infect Dis (1997) 1.35
Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother (2001) 1.30
Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun (1990) 1.29
Effects of Clostridium difficile toxins A and B on cytoskeleton organization in HEp-2 cells: a comparative morphological study. Toxicon (1989) 1.27
Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr (1998) 1.27
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun (1999) 1.25
Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay. J Med Microbiol (1994) 1.24
Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog (2000) 1.23
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics (2001) 1.23
Molecular and genomic analysis of genes encoding surface-anchored proteins from Clostridium difficile. Infect Immun (2001) 1.20
A high-affinity human antibody that targets tumoral blood vessels. Blood (1999) 1.16
Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study Group. J Clin Microbiol (2000) 1.14
Surface blebbing and cytoskeletal changes induced in vitro by toxin B from Clostridium difficile: an immunochemical and ultrastructural study. Exp Mol Pathol (1990) 1.13
Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions. J Clin Microbiol (1988) 1.07
The use of phage display for the development of tumour targeting agents. Adv Drug Deliv Rev (2000) 1.06
Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment. Nat Biotechnol (1999) 1.05
Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Italy, 1997-1999. Clin Infect Dis (2000) 1.04
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03
A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J Clin Pathol (1997) 1.00
Characterisation of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008. Euro Surveill (2009) 1.00
All classifications not built on pathogenesis become inadequate sooner or later. Diabetologia (2011) 0.99
Evidence for cross-infection in an outbreak of Clostridium difficile-associated diarrhoea in a surgical unit. J Med Microbiol (1988) 0.99
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J Infect Dis (2000) 0.98
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group. Vaccine (1998) 0.97
Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother (1991) 0.97
Molecular typing and long-term comparison of clostridium difficile strains by pulsed-field gel electrophoresis and PCR-ribotyping. J Med Microbiol (2001) 0.95
Cluster of invasive Neisseria meningitidis infections on a cruise ship, Italy, October 2012. Euro Surveill (2012) 0.95
IncI1 plasmids associated with the spread of CMY-2, CTX-M-1 and SHV-12 in Escherichia coli of animal and human origin. Clin Microbiol Infect (2013) 0.95
A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage. J Mol Biol (1999) 0.92
Role of Clostridium difficile in childhood diarrhea. Pediatr Infect Dis J (1995) 0.92
Purification and characterization of an immunodominant 36 kDa antigen present on the cell surface of Clostridium difficile. Microb Pathog (1992) 0.92
Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother (1989) 0.92
Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. J Clin Immunol (1990) 0.91
A note on fermentation reactions of anaerobic bacteria on a solid medium. J Appl Bacteriol (1982) 0.91
Polymerase chain reaction for the identification of Bordetella pertussis and Bordetella parapertussis. Diagn Microbiol Infect Dis (1996) 0.90
Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers. J Immunol Methods (1999) 0.89
Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. J Antimicrob Chemother (1989) 0.89
A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold. J Mol Biol (2001) 0.88
Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. Vaccine (2003) 0.87
NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis. Structure (1999) 0.87
[Single umbilical artery (SUA) and congenital eye abnormalities. 2 case reports]. Minerva Pediatr (1998) 0.87
Meningococcal disease in Italy. J Infect (1989) 0.86
Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol (1997) 0.86
Typing of Neisseria meningitidis isolates from patients with invasive disease by molecular analysis of porin genes. New Microbiol (2001) 0.85
Characterization of surface layer proteins from Clostridium difficile by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom (1999) 0.83
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. Climacteric (2005) 0.83
Clostridium difficile toxin A induces multinucleation in the human leukemic T cell line JURKAT. Eur J Cell Biol (1992) 0.83
Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients? J Infect Dis (2000) 0.83
Heterotopic pregnancy in a woman without previous ovarian hyperstimulation: ultrasound diagnosis and management. Eur J Obstet Gynecol Reprod Biol (1996) 0.83
Clostridium difficile: an update on virulence mechanisms. Anaerobe (1996) 0.82
IBDsite: a Galaxy-interacting, integrative database for supporting inflammatory bowel disease high throughput data analysis. BMC Bioinformatics (2012) 0.82
Superovulation with urinary human follicle-stimulating hormone: correlations with body mass index and body fat distribution. Gynecol Endocrinol (1996) 0.82
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics (2001) 0.81
Comparison of a commercially available repetitive-element PCR system (DiversiLab) with PCR ribotyping for typing of clostridium difficile strains. J Clin Microbiol (2011) 0.81
Pattern of bacterial meningitis in Italy, 1994. Eur J Epidemiol (1997) 0.81
T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice. Clin Diagn Lab Immunol (2003) 0.81
Haemophilus influenzae invasive disease in Italy, 1997-1998. Eur J Clin Microbiol Infect Dis (2001) 0.80
[Prenatal diagnosis of beta-thalassemia. A study based in Calabria]. Minerva Ginecol (2001) 0.80
Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening. Nucleic Acids Res (2001) 0.80
The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state. Microbiologica (1990) 0.80
Laparoscopic Burch colposuspension: a randomized controlled trial comparing two transperitoneal surgical techniques. Obstet Gynecol (2001) 0.79
Heterogeneity of purified cholera toxin. Biochim Biophys Acta (1977) 0.79
Capsule-like structures in Clostridium difficile strains. Microbiologica (1991) 0.79
Diversity of Neisseria meningitidis invasive isolates in Italy in the period 2008-2010. J Prev Med Hyg (2012) 0.78
Late complications after systemic methotrexate treatment of unruptured ectopic pregnancies: a report of three cases. Eur J Obstet Gynecol Reprod Biol (1996) 0.78
A risk model for ovarian carcinoma patients using CA 125: time to normalization renders second-look laparotomy redundant. Cancer (1996) 0.78
[Pregnancy management in women with thalassemia]. Minerva Ginecol (2000) 0.78
Characterization of Bordetella pertussis strains of recent isolation. New Microbiol (1999) 0.78
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. Obstet Gynecol (2001) 0.78
Ad hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27-28 July 2000. Vaccine (2001) 0.78
The human homeodomain protein OTX2 binds to the human tenascin-C promoter and trans-represses its activity in transfected cells. DNA Cell Biol (1997) 0.78
Immunogenicity issues in the quality control of the new acellular pertussis vaccines. Biologicals (1999) 0.77
WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. Biologicals (1998) 0.77
Placental growth hormone in Down's syndrome screening. J Matern Fetal Neonatal Med (2004) 0.77
Minilaparoscopic ovarian drilling under local anesthesia in patients with polycystic ovary syndrome. Fertil Steril (2000) 0.77
Haemagglutination and surface structures in strains of Clostridium spiroforme. FEMS Microbiol Lett (1989) 0.77
Synthesis and pharmacological evaluation of a new class of 2-(2-aminothiazol-4-yl)-2-hydrazonoacetamido cephalosporins. J Med Chem (1987) 0.76
Lactobacillus brevis CD2 inhibits Prevotella melaninogenica biofilm. Oral Dis (2013) 0.76
Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines. Dev Biol Stand (1997) 0.75
Roxithromycin disposition in tonsils after single and repeated administrations. Antimicrob Agents Chemother (1988) 0.75
A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors. Am J Obstet Gynecol (1998) 0.75
The human tenascin-R gene. J Biol Chem (1996) 0.75
High homology of membrane proteins electrophoretic pattern in Bacteroides fragilis as confirmed by various solubilizing methods. Microbiologica (1986) 0.75
Randomized clinical trial of short-term antibiotic prophylaxis in 750 patients undergoing vaginal and abdominal hysterectomy. Int Surg (1984) 0.75
Impact of lenampicillin on the fecal flora of healthy volunteers. J Chemother (1989) 0.75
Infections in the surgical setting: epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients. Am J Surg (1992) 0.75
[Behavior of plasma testosterone in vesicular mole]. Arch Ostet Ginecol (1981) 0.75
Thiamphenicol in the prophylaxis and treatment of mixed infections of the female genital tract. Sex Transm Dis (1985) 0.75
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies. Clin Microbiol Infect (2002) 0.75
[Behavior of placental lactogen in vesicular mole]. Arch Ostet Ginecol (1981) 0.75
[SP1 beta 1-glycoprotein and vesicular mole]. Arch Ostet Ginecol (1981) 0.75